{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:47:28Z","timestamp":1789706848002,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.sapharm.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:50:53Z","timestamp":1646913053000},"page":"3588-3595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of policies and practices to support safe and appropriate analgesic and sedative prescribing: The CDRx (controlled drug prescribing) protocol"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-3613","authenticated-orcid":false,"given":"Molly","family":"Mattsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Kirke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"MacKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.sapharm.2022.03.004_bib1","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.17.198002","article-title":"The third global patient safety challenge: tackling medication-related harm","volume":"95","author":"Sheikh","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.sapharm.2022.03.004_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamainternmed.2018.7934","article-title":"Opioid prescribing trends and the physician's role in responding to the public health crisis","volume":"179","author":"Adams","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"23","key":"10.1016\/j.sapharm.2022.03.004_bib3","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.sapharm.2022.03.004_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.sapharm.2022.03.004_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2215-0366(18)30471-1","article-title":"Opioid prescribing trends and geographical variation in England, 1998\u20132018: a retrospective database study","volume":"6","author":"Curtis","year":"2019","journal-title":"Lancet Psychiatr"},{"issue":"8","key":"10.1016\/j.sapharm.2022.03.004_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/pds.5247","article-title":"Trends in strong opioid prescribing in Ireland: a repeated cross-sectional analysis of a national pharmacy claims database between 2010 and 2019","volume":"30","author":"Norris","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.sapharm.2022.03.004_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008656","article-title":"Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study","volume":"5","author":"Moriarty","year":"2015","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib8","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015","volume":"84","author":"Cadogan","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00228-020-03063-z","article-title":"Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study","volume":"77","author":"Cadogan","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2022.03.004_bib10","series-title":"National Healthcare Quality Reporting System Annual Report 2020","year":"2020"},{"key":"10.1016\/j.sapharm.2022.03.004_bib11","series-title":"Ensuring Balance in National Policies on Controlled Substances: Guidance for Availability and Accessibility of Controlled Medicines","year":"2011"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the centers for disease control and prevention's 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/bcpt.12347","article-title":"Reducing prescriptions of long-acting benzodiazepine drugs in Denmark: a descriptive analysis of nationwide prescriptions during a 10-year period","volume":"116","author":"Eriksen","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"8","key":"10.1016\/j.sapharm.2022.03.004_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jamainternmed.2016.2992","article-title":"Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: taking control of prescription drug use","volume":"176","author":"Schaffer","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.sapharm.2022.03.004_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugpo.2016.10.008","article-title":"Alprazolam in fatal overdose following regulatory rescheduling: a response to Deacon et al","volume":"39","author":"Lloyd","year":"2017","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.sapharm.2022.03.004_bib16","article-title":"Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis","volume":"361","author":"Martin","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.sapharm.2022.03.004_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2710.2011.01245.x","article-title":"The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature","volume":"37","author":"Fisher","year":"2012","journal-title":"J Clin Pharm Ther. Feb"},{"key":"10.1016\/j.sapharm.2022.03.004_bib18","series-title":"Statutory Instrument No. 173\/2017 - Misuse of Drugs Regulations","year":"2017"},{"key":"10.1016\/j.sapharm.2022.03.004_bib19","doi-asserted-by":"crossref","first-page":"d1513","DOI":"10.1136\/bmj.d1513","article-title":"Time to tackle unwarranted variations in practice","volume":"342","author":"Wennberg","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.sapharm.2022.03.004_bib20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00228-017-2310-7","article-title":"Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data","volume":"73","author":"Sinnott","year":"2017","journal-title":"Eur J Clin Pharmacol. Nov"},{"key":"10.1016\/j.sapharm.2022.03.004_bib22","author":"Centre"},{"key":"10.1016\/j.sapharm.2022.03.004_bib23","author":"Library"},{"key":"10.1016\/j.sapharm.2022.03.004_bib24","series-title":"Health Care Quality Indicators","year":"2017"},{"key":"10.1016\/j.sapharm.2022.03.004_bib25","series-title":"Realistic Prescribing","author":"Polypharmacy Guidance","year":"2018"},{"issue":"3","key":"10.1016\/j.sapharm.2022.03.004_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2014.82","article-title":"Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis","volume":"109","author":"Anglin","year":"2014","journal-title":"Am J Gastroenterol. Jun"},{"issue":"1","key":"10.1016\/j.sapharm.2022.03.004_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12916-020-01528-7","article-title":"Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis","volume":"18","author":"Richards","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.sapharm.2022.03.004_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40258-020-00586-5","article-title":"Effect of an online reimbursement application system on prescribing of lidocaine 5% medicated plaster in the republic of Ireland","volume":"19","author":"Smith","year":"2021","journal-title":"Appl Health Econ Health Pol"},{"issue":"4","key":"10.1016\/j.sapharm.2022.03.004_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther. Aug"},{"issue":"8","key":"10.1016\/j.sapharm.2022.03.004_bib31","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/sim.1970","article-title":"Funnel plots for comparing institutional performance","volume":"24","author":"Spiegelhalter","year":"2005","journal-title":"Stat Med."},{"issue":"10","key":"10.1016\/j.sapharm.2022.03.004_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7100320","article-title":"Prescribing variation in general practices in England following a direct healthcare professional communication on mirabegron","volume":"7","author":"Moriarty","year":"2018","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.sapharm.2022.03.004_bib33","article-title":"Analysis of primary care prescription trends in England during the COVID-19 pandemic compared against a predictive model","volume":"9","author":"Frazer","year":"2021","journal-title":"Fam Med Commun Health"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jep.12756","article-title":"Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach","volume":"23","author":"Losby","year":"2017","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.sapharm.2022.03.004_bib36","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2022.03.004_bib37","series-title":"ICGP Submission to the Joint Committee on Health on Prescribing Pattern Monitoring","year":"2018"},{"key":"10.1016\/j.sapharm.2022.03.004_bib38","series-title":"Guidance on Appropriate Prescribing of Benzodiazepines and Zdrugs for the Treatment of Anxiety and Insomnia (BZRA) (Medicines Management Programme)","year":"2021"},{"issue":"1","key":"10.1016\/j.sapharm.2022.03.004_bib39","doi-asserted-by":"crossref","DOI":"10.2196\/10929","article-title":"Measuring the impact of an open web-based prescribing data analysis service on clinical practice: cohort study on NHS England data","volume":"21","author":"Walker","year":"2019","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.sapharm.2022.03.004_bib40","doi-asserted-by":"crossref","first-page":"l236","DOI":"10.1136\/bmj.l236","article-title":"Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial","volume":"364","author":"Gulliford","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.sapharm.2022.03.004_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/jac\/dky509","article-title":"Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care","volume":"74","author":"Croker","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.sapharm.2022.03.004_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2022.03.004_bib43","series-title":"Primary Care Reimbursement Service: Statistical Analysis of Claims and Payments 2020","year":"2020"},{"issue":"3","key":"10.1016\/j.sapharm.2022.03.004_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000092116","article-title":"Socioeconomic influences on benzodiazepine consumption in an Irish Region","volume":"12","author":"Quigley","year":"2006","journal-title":"Eur Addict Res"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741122000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741122000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:27:36Z","timestamp":1761557256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741122000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1551741122000596"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2022.03.004","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of policies and practices to support safe and appropriate analgesic and sedative prescribing: The CDRx (controlled drug prescribing) protocol","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}